Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
Certified by Founder
Lodge
Apnimed
start up
United States
- Cambridge, Massachusetts
- 04/05/2022
- Series C
- $62,500,000
Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders.
- Industry Pharmaceuticals
- Website https://apnimed.com/
- LinkedIn https://www.linkedin.com/company/apnimed/about/
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)